HealthEquity, Inc. (HQY) Upgraded at BidaskClub
BidaskClub upgraded shares of HealthEquity, Inc. (NASDAQ:HQY) from a sell rating to a hold rating in a research report sent to investors on Tuesday.
Other analysts have also recently issued reports about the company. TheStreet raised HealthEquity from a c rating to a b rating in a research note on Monday, July 31st. Oppenheimer Holdings, Inc. reissued a buy rating and set a $61.00 target price on shares of HealthEquity in a research note on Wednesday, September 6th. Cantor Fitzgerald reissued a buy rating and set a $56.00 target price on shares of HealthEquity in a research note on Tuesday, September 5th. Zacks Investment Research raised shares of HealthEquity from a hold rating to a buy rating and set a $54.00 price target for the company in a research note on Wednesday, July 12th. Finally, Robert W. Baird reaffirmed a hold rating on shares of HealthEquity in a research note on Thursday, September 21st. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company has a consensus rating of Buy and an average price target of $57.50.
HealthEquity (HQY) traded down $1.03 during midday trading on Tuesday, reaching $49.74. The company had a trading volume of 307,575 shares, compared to its average volume of 538,051. HealthEquity has a twelve month low of $37.62 and a twelve month high of $55.31. The company has a market cap of $3,010.00, a PE ratio of 79.44, a price-to-earnings-growth ratio of 2.19 and a beta of 1.77.
HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.13. HealthEquity had a return on equity of 13.93% and a net margin of 20.27%. The business had revenue of $56.90 million during the quarter, compared to analysts’ expectations of $55.66 million. During the same period in the prior year, the business earned $0.16 EPS. HealthEquity’s revenue for the quarter was up 28.7% compared to the same quarter last year. analysts anticipate that HealthEquity will post 0.7 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “HealthEquity, Inc. (HQY) Upgraded at BidaskClub” was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was stolen and republished in violation of U.S. and international trademark & copyright law. The original version of this story can be viewed at https://www.watchlistnews.com/healthequity-inc-hqy-upgraded-at-bidaskclub/1694075.html.
In other news, major shareholder Berkley Capital, Llc sold 1,100 shares of the stock in a transaction that occurred on Monday, October 9th. The stock was sold at an average price of $51.95, for a total value of $57,145.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Stephen Neeleman sold 8,500 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $46.65, for a total value of $396,525.00. Following the completion of the sale, the insider now directly owns 1,000 shares of the company’s stock, valued at approximately $46,650. The disclosure for this sale can be found here. Insiders have sold a total of 1,572,091 shares of company stock valued at $81,916,281 over the last ninety days. Company insiders own 29.00% of the company’s stock.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Oppenheimer Asset Management Inc. acquired a new stake in shares of HealthEquity in the 1st quarter valued at approximately $106,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of HealthEquity by 105.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock valued at $127,000 after buying an additional 1,308 shares during the last quarter. Riverhead Capital Management LLC boosted its holdings in shares of HealthEquity by 75.3% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock valued at $131,000 after buying an additional 1,129 shares during the last quarter. Exane Derivatives acquired a new stake in shares of HealthEquity in the 2nd quarter valued at approximately $132,000. Finally, Fortaleza Asset Management Inc. acquired a new stake in shares of HealthEquity in the 2nd quarter valued at approximately $138,000. 91.40% of the stock is owned by institutional investors.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.